Investing.com - Novo Nordisk (CSE:NOVOb) ADR reported on Friday first quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Novo Nordisk ADR announced earnings per share of kr0.8944 on revenue of kr5.96B. Analysts polled by Investing.com anticipated EPS of kr0.8466 on revenue of kr5.77B.
Novo Nordisk ADR shares are up 1.79% from the beginning of the year and are trading at kr114.25 , down-from-52-week-high.They are outperforming the EUR/USD which is down 0% from the start of the year.
Novo Nordisk ADR follows other major Healthcare sector earnings this month
Novo Nordisk ADR's report follows an earnings beat by UnitedHealth on April 14, who reported EPS of kr5.49 on revenue of kr80.15B, compared to forecasts EPS of kr5.36 on revenue of kr78.73B.
J&J had beat expectations on April 19 with first quarter EPS of kr2.67 on revenue of kr23.43B, compared to forecast for EPS of kr2.59 on revenue of kr23.62B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar